Lunch Presentation: Coya Therapeutics NASDAQ COYA

​Our guest speakers, Dr. Howard Berman, Chairman of the Board, and Dr. Arun Swaminathan, CEO of Coya Therapeutics, Inc. will discuss the company’s vision, achievements, and milestones in 2025 and beyond.

​Coya Therapeutics, Inc., is a leading clinical stage company focused on developing multi-modality Treg therapies for neurodegenerative autoimmune, and metabolic diseases. They have demonstrated strong proof of concept data in Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s Disease demonstrating disease stabilization. You should attend if you are interested in this research and company. A Family Office, fund/wealth/asset manager, trader or active investor interested in healthcare.

​Please only RSVP if you are confident of attending.